Morgan Stanley’s AIM ImmunoTech Inc. AIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.59K Sell
762
-1
-0.1% -$9 ﹤0.01% 6957
2025
Q1
$9.33K Hold
763
﹤0.01% 6821
2024
Q4
$15.1K Sell
763
-80
-9% -$1.58K ﹤0.01% 6656
2024
Q3
$22.8K Sell
843
-10
-1% -$270 ﹤0.01% 6469
2024
Q2
$31.8K Hold
853
﹤0.01% 6316
2024
Q1
$40.2K Sell
853
-693
-45% -$32.6K ﹤0.01% 6298
2023
Q4
$68K Sell
1,546
-977
-39% -$43K ﹤0.01% 6288
2023
Q3
$115K Sell
2,523
-1,833
-42% -$83.4K ﹤0.01% 5822
2023
Q2
$292K Sell
4,356
-1,750
-29% -$117K ﹤0.01% 5472
2023
Q1
$263K Sell
6,106
-3,060
-33% -$132K ﹤0.01% 5582
2022
Q4
$286K Sell
9,166
-4,818
-34% -$150K ﹤0.01% 5514
2022
Q3
$814K Sell
13,984
-2,009
-13% -$117K ﹤0.01% 5000
2022
Q2
$1.25M Sell
15,993
-3,928
-20% -$307K ﹤0.01% 4879
2022
Q1
$2.11M Sell
19,921
-493
-2% -$52.3K ﹤0.01% 4485
2021
Q4
$1.88M Sell
20,414
-3,430
-14% -$316K ﹤0.01% 4636
2021
Q3
$4.82M Sell
23,844
-1,230
-5% -$248K ﹤0.01% 3757
2021
Q2
$5.39M Buy
25,074
+14
+0.1% +$3.01K ﹤0.01% 3702
2021
Q1
$5.69M Buy
25,060
+15,072
+151% +$3.42M ﹤0.01% 3275
2020
Q4
$1.79M Buy
9,988
+1,934
+24% +$346K ﹤0.01% 4250
2020
Q3
$1.73M Buy
8,054
+3,291
+69% +$708K ﹤0.01% 3786
2020
Q2
$1.18M Buy
4,763
+4,581
+2,517% +$1.14M ﹤0.01% 4046
2020
Q1
$46K Buy
182
+181
+18,100% +$45.7K ﹤0.01% 5497
2019
Q4
$0 Sell
1
-1,438
-100% ﹤0.01% 7012
2019
Q3
$110K Buy
+1,439
New +$110K ﹤0.01% 5411
2019
Q2
Hold
0
6972
2019
Q1
Hold
0
6970
2018
Q4
Hold
0
7014
2018
Q3
Hold
0
7048
2018
Q2
Hold
0
7036
2018
Q1
Hold
0
6929
2017
Q4
Hold
0
6932
2017
Q3
Hold
0
-$1K 6871
2017
Q2
Hold
0
-$1K 6571
2017
Q1
Hold
0
6558
2015
Q2
Sell
-1
Closed -$10K 7061
2015
Q1
$10K Sell
1
-3
-75% -$30K ﹤0.01% 6234
2014
Q4
$58K Buy
+4
New +$58K ﹤0.01% 5774